Company profile for Neoleukin Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Neoleukin Therapeutics, we are dedicated to developing medicines that transform lives. We believe that there is an urgent need for a paradigm shift in therapeutic protein discovery that overcomes a reliance on the building blocks that nature has provided.Our innovative computational platform allows us to design entirely new – de novo – proteins from the ground up to treat serious diseases, including cancer, inflammatory...
At Neoleukin Therapeutics, we are dedicated to developing medicines that transform lives. We believe that there is an urgent need for a paradigm shift in therapeutic protein discovery that overcomes a reliance on the building blocks that nature has provided.Our innovative computational platform allows us to design entirely new – de novo – proteins from the ground up to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. We are a team of physicians, scientists, and innovators with a visionary focus to improve on nature and enable a truly customized approach to medicine.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1616 Eastlake Avenue E #360 Seattle WA 98102
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20231219056613/en

BUSINESSWIRE
19 Dec 2023

https://www.globenewswire.com//news-release/2023/12/15/2796782/0/en/Neoleukin-Therapeutics-Announces-1-for-4-Reverse-Stock-Split.html

GLOBENEWSWIRE
14 Dec 2023

https://www.globenewswire.com//news-release/2023/09/22/2747927/0/en/Neoleukin-Therapeutics-Announces-1-for-5-Reverse-Stock-Split.html

GLOBENEWSWIRE
22 Sep 2023
Neurogene inks Neoleukin reverse merger to fund gene therapies
Neurogene inks Neoleukin reverse merger to fund gene therapies

18 Jul 2023

// Nick Paul Taylor FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/neurogene-inks-neoleukin-reverse-merger-raises-95m-fund-gene-therapies-clinical-data-drops

Nick Paul Taylor FIERCE BIOTECH
18 Jul 2023

https://endpts.com/neoleukin-sends-70-of-staff-packing-as-il-2-biotech-searches-for-sale-or-other-exit/

ENDPTS
10 Mar 2023

https://www.globenewswire.com//news-release/2022/12/12/2572217/0/en/Neoleukin-Therapeutics-Presents-Preclinical-Data-on-NEO-TRA1-at-American-Society-of-Hematology-ASH-Annual-Meeting.html

GLOBENEWSWIRE
12 Dec 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty